Yubo International Biotech Limited（YBGJ）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · YBGJ · 截至 2026-06-15

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2022-12	2021-12	2020-12
Revenue
Revenue	$0.13M	$0.00M	$0.10M	$1.24M	$1.35M
Cost of Revenue	$0.13M	$0.21M	$0.05M	$0.42M	$0.11M
Gross Profit	$0.01M	($0.21M)	$0.05M	$0.82M	$1.24M
Gross Margin %(computed)	6.08%	—	50.49%	65.95%	91.56%
Operating Expenses
R&D Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
G&A Expenses	$0.88M	$1.25M	$1.04M	$1.31M	$0.54M
Total Operating Expenses	$1.20M	$1.56M	$1.26M	$2.36M	$1.95M
Operating Income	($1.19M)	($1.77M)	($1.21M)	($1.54M)	($0.71M)
Operating Margin %(computed)	-883.76%	—	—	-123.99%	-52.58%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	($0.00M)	$0.00M	$0.00M	$427.00M	$0.00M
Income Before Tax	($1.19M)	($1.98M)	($1.20M)	($1.54M)	($0.71M)
Income Tax Expense	($0.11M)	($0.21M)	($0.00M)	($0.00M)	$0.00M
Net Income	($1.08M)	($1.78M)	($1.20M)	($1.54M)	($0.71M)
Net Margin %(computed)	-803.07%	—	—	-123.92%	-52.58%
Per Share & EBITDA
EPS (Basic)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01
Wtd Avg Shares	139.64M	119.82M	118.72M	118.13M	118.18M
EBITDA	($1.01M)	($1.80M)	($1.18M)	($1.52M)	($0.70M)
EBITDA Margin %(computed)	-751.48%	—	—	-122.27%	-51.61%